Pulmonary carcinoids are rare tumors of the lung with extremely different clinical courses. In many patients, they behave like benign tumors; surgical removal of the tumor leads to a complete cure. However, some patients experience aggressive growth and spread (metastasis) of the tumor with poor chances of recovery. The biological causes of these different forms of the disease are still unknown.
CureVac’s CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma Presented at the ESMO 2024 Congress – Biotech Investments
Issuer: CureVac / Key word(s): Conference/Study results 13.09.2024 / 13:57 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac’s CVGBM Cancer